Neofect Co. Ltd. (290660) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Neofect Co. Ltd. (290660:KRX), powered by AI.

Current Price
₩1,010
P/E Ratio
-44.3
Market Cap
85.0B
Sector
Healthcare
What is the Neofect Co. Ltd. stock price forecast?

Neofect Co. Ltd. is currently trading at ₩1,010. View real-time AI analysis on Alpha Lenz.

What is Neofect Co. Ltd. insider trading activity?

View the latest insider trading data for Neofect Co. Ltd. on Alpha Lenz.

What is Neofect Co. Ltd.'s P/E ratio?

Neofect Co. Ltd.'s P/E ratio is -44.3.

Neofect Co. Ltd.

KRX · 290660
₩1,010
Ask about Neofect Co. Ltd.'s future dividend policy...
Alpha Chat Insight

Neofect Co. Ltd. trades at a P/E of -44.3 (undervalued) with modest ROE of -2.8%.

Ask for details

Company Overview

Neofect Co. Ltd. is a specialized healthcare technology company focusing on the innovation and development of neuro-rehabilitation devices. Its primary function is to create advanced rehabilitation solutions aimed at improving the quality of life for patients recovering from neurological and musculoskeletal disorders. Neofect is renowned for its cutting-edge robotic and AI-driven products, such as robotic gloves and smart rehabilitation systems, which facilitate personalized and engaging therapy experiences. These technologies are particularly impactful in the healthcare sector, where they are utilized by hospitals, rehabilitation centers, and individual patients globally. The company plays a vital role in enhancing therapeutic outcomes, driven by its emphasis on making rehabilitation accessible and efficient. Founded in South Korea, Neofect has positioned itself as a significant player within the global medical technology market, continually expanding its product offerings to adapt to the increasing demands for innovative rehabilitation solutions.

CEO백명훈
SectorHealthcare
IndustryMedical Devices
Employees57

Company Statistics

FY 2024

Profile

₩84,967,746,820Market Cap
₩21,111,727,660Revenue
84.13MShares Out
57Employees

Margins

46.18%Gross
41.68%EBITDA
-11.43%Operating
-8.72%Pre-Tax
-6.95%Net

Valuation

-44.26P/E
1.08P/B
1.99EV/Sales
4.96EV/EBITDA
-28.85P/FCF

Growth (CAGR)

-3.04%Rev 3Yr
11.39%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-2.04%ROA
-2.81%ROE
3.24%ROIC

Financial Health

₩22,086,813,980Cash & Cash Equivalents
₩12,017,235,980Net Debt
89.15%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Neofect Co. Ltd. (ticker: 290660) is a company listed on KRX in the Healthcare sector (Medical Devices). It has approximately 57 employees. Market cap is $85.0B.

The current price is ₩1,010 with a P/E ratio of -44.26x and P/B of 1.08x.

ROE is -2.81% and operating margin is -11.43%. Annual revenue is $21.1B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Neofect Co. Ltd. (Healthcare) Stock Forecast & Analysis ₩1,010 | Alpha Lenz